Quote | Skye Bioscience Inc Com (OTCMKTS:SKYE)
Last: | $14.81 |
---|---|
Change Percent: | -5.81% |
Open: | $15.67 |
Close: | $14.81 |
High: | $16.01 |
Low: | $14.005 |
Volume: | 216,501 |
Last Trade Date Time: | 04/22/2024 03:00:00 am |
News | Skye Bioscience Inc Com (OTCMKTS:SKYE)
2024-05-30 14:07:56 ET More on Dollar General, IZEA Worldwide, etc. Dollar General Corporation (DG) Q1 2024 Earnings Call Transcript Modine Manufacturing: AI Growth Stock Surged More Than 250% In One Year SentinelOne Q1 Earnings Preview: Growth Momentum, Despite Peer...
2024-05-30 13:35:28 ET More on CRH, Microvast Holdings, etc. Workhorse Group Inc. (WKHS) Q1 2024 Earnings Call Transcript CRH Is Poised To Benefit From A Major Growth Cycle Pagaya: Patience Should Pay Off Nikola discloses order of 100 hydrogen fuel cell truck...
Message Board Posts | Skye Bioscience Inc Com (OTCMKTS:SKYE)
Subject | By | Source | When |
---|---|---|---|
NEWS: Skye Bioscience Begins Dosing Phase 1 Fourth | lolroflmao | investorshub | 04/27/2023 11:55:45 AM |
News: Skye Bioscience Receives Positive Safety Review of | lolroflmao | investorshub | 04/04/2023 1:31:37 PM |
News: Skye Bioscience's Novel Cannabinoid Derivative Reduces Pain | lolroflmao | investorshub | 04/03/2023 1:02:54 PM |
Don't live for the approval of others. Only | WallStreetMyWay | investorshub | 03/16/2023 8:20:56 AM |
NEWS: Skye Bioscience Receives Human Research Ethics Committee Approval | lolroflmao | investorshub | 03/15/2023 12:39:10 PM |
News, Short Squeeze, Breakout and More Instantly...
Skye Bioscience Inc Com Company Name:
SKYE Stock Symbol:
OTCMKTS Market:
SAN DIEGO, May 10, 2024 (GLOBE NEWSWIRE) -- Skye Bioscience, Inc. (Nasdaq: SKYE) (“Skye”), a clinical-stage biotechnology company focused on the discovery, development and commercialization of novel classes of therapeutic drugs that modulate the endocannabinoid system (ECS), today a...
--News Direct-- Skye Bioscience CEO Punit Dhillon joined Steve Darling from Proactive to share news announcing the company's uplisting of its common stock to the Nasdaq stock exchange, trading under the ticker symbol "SKYE." This achievement signifies a significant milestone for the compa...
SAN DIEGO, April 30, 2024 (GLOBE NEWSWIRE) -- Skye Bioscience, Inc. (Nasdaq: SKYE) (“Skye”), a clinical-stage biotechnology company focused on the discovery, development and commercialization of novel classes of therapeutic drugs that modulate the endocannabinoid system, today annou...